Evidence map›Paper›PMID 42165338›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

2-aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease.

Anum Saeed, Chris Mckennan, Jane E Clougherty, Peidi Zhou, Sheila Tripathy, Ellen J Kinnee, Jiaxuan Duan, Kevin Kip, Xuemei Zeng, Victor Villemagne and 9 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. 2-aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anum SaeedUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-1783-678X
Chris MckennanUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jane E CloughertyDrexel University, Philadelphia, Pennsylvania, USA.
Peidi ZhouUniversity of Texas Health Sciences, Houston, Texas, USA.
Sheila TripathyDrexel University, Philadelphia, Pennsylvania, USA.
Ellen J KinneeUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jiaxuan DuanUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kevin KipUPMC Analytics, UPMC, Pittsburgh, Pennsylvania, USA.
Xuemei ZengUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Victor VillemagneUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Tharick PascoalUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Mark MapstoneUniversity of California Irvine, Irvine, California, USA.
Eric A WhitselUniversity of North Carolina, Chapel Hill, North Carolina, USA.
Oscar I LopezUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Christie BallantyneBaylor College of Medicine, Houston, Texas, USA.
Thomas K KarikariUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Bing YuUniversity of Texas Health Sciences, Houston, Texas, USA.
Steven ReisUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Annie CohenUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Funding

Vascular Moderators of the Impact of Alzheimer's Pathology in the Young-OldP01AG025204 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Ann D. Cohen · 2005 to 2026
$56.5M
Longitudinal multicenter head-to-head harmonization of tau PET tracersR01AG073267 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAKER, SUZANNE L, PASCOAL, THARICK · 2021 to 2025
$41.1M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Mild Cognitive Impairment: A Prospective Community StudyR37AG023651 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Carmen Andreescu, MARY GANGULI · 2021 to 2026
$18.2M
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in bloodR01AG083874 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas K Karikari · 2023 to 2026
$14.5M
The RAW Brain - The Effect of Rumination, Anxiety and Worry on Aging and Dementia RiskR01MH108509 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Carmen Andreescu · 2016 to 2026
$10.6M
Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities FrameworkR01AG072641 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ann D. Cohen · 2022 to 2026
$9.6M
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC NetworkU24AG082930 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Nicole R. Fowler, Thomas K Karikari · 2023 to 2026
$7.3M
Examining the Persistence of Neurocognitive Benefits of ExerciseR01AG083156 · NIA · ADVENTHEALTH ORLANDO · PI ERICKSON, KIRK I · 2023 to 2025
$6.8M
Analytical characterization and validation of blood-biomarkers for monitoring TBI evolutionU01NS131740 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ramon Diaz-Arrastia, Ava M. Puccio · 2024 to 2026
$4.7M
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD PathophysiologyR01AG025516 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Victor Luis Villemagne · 2024 to 2026
$4.4M
Aging Mind Foundation DAF2255207and National Institutes of Healthby American Heart Association 23CDA1055489DoD HT94252320064NHLBI NIH HHS R01 HL089292NIA NIH HHS P01 AG025204NIA NIH HHS P30 AG066468NIA NIH HHS R01 AG025516NIA NIH HHS R01 AG072641NIA NIH HHS R01 AG073267NIA NIH HHS R01 AG075336NIA NIH HHS R01 AG083156NIA NIH HHS R01 AG083874NIA NIH HHS R37 AG023651NIA NIH HHS RF1 AG077474NIA NIH HHS U24 AG082930NIEHS NIH HHS P30 ES010126NIH/NIA R01 AG083874 U24AG082930 P30 AG066468 RF1 AG077474 R01 AG083156 R37 AG023651 R01 AG025516 R01 AG073267 R01 AG075336 R01 AG072641 P01 AG025204NIH/NINDS U01 NS131740 U01 NS141777NIMH NIH HHS R01 MH108509NINDS NIH HHS U01 NS131740NINDS NIH HHS U01 NS141777the Anbridge Charitable Fundthe Department of Psychiatry, University of Pittsburghthe Pennsylvania Department of Health ME-02-384
6 · The paper itself

Abstract

introductionWe examined the impact of mid-life metabolites on late-life Alzheimer's disease (AD) plasma biomarkers and whether these metabolites mediate air pollution effects.

methodsIn the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) cohort, we applied high-dimensional regression and meditation models, adjusting for observed and latent confounders, with replication in the Atherosclerosis Risk in Communities (ARIC) study. Exposures included mid-life fine particulate matter (PM

resultsIn the Heart SCORE study, seven lipid- and amnio acid-pathway metabolites measured in mid-life were significantly inversely associated with late-life p-tau181 levels (false discovery rate ≤ 15%) and showed a nominal inverse association with p-tau217 and 231 (P < 0.05). 2-aminobutyrate was associated with mid-life PM DISCUSSION: Mid-life metabolite profiles, particularly 2-aminobutyrate, may predict and mediate air pollution-related AD risk. HIGHLIGHTS: Seven mid-life metabolites were inversely linked to late-life plasma phosphorylated tau (p-tau)181. 2-aminobutyrate was tied to fine particulate matter (PM

Indexed as

Air PollutionAlzheimer DiseaseAgedAmyloid beta-PeptidesBiomarkersFemaleHumansMaleParticulate MatterPeptide Fragmentstau ProteinsAmyloid beta-Peptidesamyloid beta-protein (1-42)BiomarkersParticulate MatterPeptide Fragmentstau Proteinsair pollutionAlzheimer's diseaseAlzheimer's disease preventionphosphorylated tauPM2.5

Identifiers

PMID42165338
PMCPMC13239731

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.